Raymond James Financial Services Advisors’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-155
| Closed | -$11.9K | – | 3266 |
|
|
2023
Q1 | $11.9K | Hold |
155
| – | – | ﹤0.01% | 3202 |
|
|
2022
Q4 | $14K | Sell |
155
-169
| -52% | -$15.2K | ﹤0.01% | 3154 |
|
|
2022
Q3 | $18K | Sell |
324
-33
| -9% | -$1.83K | ﹤0.01% | 3149 |
|
|
2022
Q2 | $42K | Buy |
357
+5
| +1% | +$588 | ﹤0.01% | 3082 |
|
|
2022
Q1 | $101K | Buy |
352
+216
| +159% | +$62K | ﹤0.01% | 3092 |
|
|
2021
Q4 | $45K | Buy |
136
+18
| +15% | +$5.96K | ﹤0.01% | 3174 |
|
|
2021
Q3 | $59K | Buy |
118
+25
| +27% | +$12.5K | ﹤0.01% | 3156 |
|
|
2021
Q2 | $51K | Sell |
93
-2
| -2% | -$1.1K | ﹤0.01% | 3180 |
|
|
2021
Q1 | $59K | Buy |
+95
| New | +$59K | ﹤0.01% | 3073 |
|